Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Mechanisms of MYCN Dysregulation in Cancers
Ruochen Liu, Pengfei Shi, Zhongze Wang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Molecular principles underlying aggressive cancers
Ruth Nussinov, Bengi Ruken Yavuz, Hyunbum Jang
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders
Jian Tang, Ramkumar Moorthy, Laura Hirsch, et al.
Cell chemical biology (2025)
Open Access | Times Cited: 2
Major Changes in 2021 World Health Organization Classification of Central Nervous System Tumors
Ryo Kurokawa, Mariko Kurokawa, Akira Baba, et al.
Radiographics (2022) Vol. 42, Iss. 5, pp. 1474-1493
Closed Access | Times Cited: 42
Small Cell Lung Cancer—An Update on Chemotherapy Resistance
Ying Qian, Ruiyun Fan, Yili Shen, et al.
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1112-1123
Closed Access | Times Cited: 8
NDRG1 in Cancer: A Suppressor, Promoter, or Both?
Vaibhavi Joshi, Sunil R. Lakhani, Amy E. McCart Reed
Cancers (2022) Vol. 14, Iss. 23, pp. 5739-5739
Open Access | Times Cited: 31
The Myc Family and the Metastasis Suppressor NDRG1: Targeting Key Molecular Interactions with Innovative Therapeutics
Zhao Deng, Des R. Richardson
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 1007-1035
Open Access | Times Cited: 14
Competing Endogenous RNA Networks in Glioma
Liang Cen, Ruochen Liu, Wei Liu, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 32
Insights into the Clinical, Biological and Therapeutic Impact of Copy Number Alteration in Cancer
Shannon L. Carey-Smith, Rishi S. Kotecha, Laurence C. Cheung, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6815-6815
Open Access | Times Cited: 4
GDP-mannose 4,6-dehydratase is a key driver of MYCN-amplified neuroblastoma core fucosylation and tumorigenesis
Beibei Zhu, Michelle G. Pitts, Michael D. Buoncristiani, et al.
Oncogene (2025)
Open Access
Novel C-2 Aromatic Heterocycle-Substituted Triterpenoids Inhibit Hedgehog Signaling in GLI1 Overexpression Cancer Cells
Ivo Frydrych, Barbora Choma, Lenka Slavíková, et al.
ACS Omega (2025) Vol. 10, Iss. 10, pp. 10617-10632
Open Access
Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Identification of gene signatures and transcription factors associated with colorectal cancer through computational based approach
Shoufia Jabeen Mubarak, Hemamalini Vedagiri
Human Gene (2025), pp. 201405-201405
Closed Access
An Introduction to Fundamentals of Cancer Biology
S. Sriharikrishnaa, Padmanaban S. Suresh, Shama Prasada Kabekkodu
Biological and medical physics series (2023), pp. 307-330
Closed Access | Times Cited: 9
CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness
Xiaodan Qin, Andrew Lam, Xu Zhang, et al.
Science Advances (2024) Vol. 10, Iss. 11
Open Access | Times Cited: 3
Typical Enhancers, Super-Enhancers, and Cancers
Marianna A. Koutsi, Marialena Pouliou, Lydia Champezou, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4375-4375
Open Access | Times Cited: 15
Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma
Marlies Vanden Bempt, Koen Debackere, Sofie Demeyer, et al.
Blood (2022) Vol. 140, Iss. 23, pp. 2463-2476
Open Access | Times Cited: 14
Exploring new roles for RNA-binding proteins in epigenetic and gene regulation
Pedro Antonio Ávila-López, Shannon Lauberth
Current Opinion in Genetics & Development (2023) Vol. 84, pp. 102136-102136
Closed Access | Times Cited: 8
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma
Kai Voeltzke, Katerina Scharov, Cornelius M. Funk, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 10
Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
Jyotirmayee Talapatra, Mamatha M. Reddy
Cancers (2023) Vol. 15, Iss. 7, pp. 2144-2144
Open Access | Times Cited: 5
MYCN Amplifications and Metabolic Rewiring in Neuroblastoma
Marialena Pouliou, Marianna A. Koutsi, Lydia Champezou, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4803-4803
Open Access | Times Cited: 5
Synergistic efficacy of inhibiting MYCN and mTOR signaling against neuroblastoma
Matthew J. Kling, Connor N. Griggs, Erin M. McIntyre, et al.
BMC Cancer (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 12
The Novel Artemisinin Dimer Isoniazide ELI-XXIII-98-2 Induces c-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells
Mohamed Elbadawi, Joelle C. Boulos, Mona Dawood, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1107-1107
Open Access | Times Cited: 4
The Potential Role of Immunotherapy in Wilms’ Tumor: Opportunities and Challenges
Seyed Amir Sanatkar, Arash Heidari, Shahrzad Arya, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 20, pp. 1617-1627
Closed Access | Times Cited: 4
Single-cell chromatin accessibility reveals malignant regulatory programs in primary human cancers
Laksshman Sundaram, Arvind Kumar, Matthew Zatzman, et al.
Science (2024) Vol. 385, Iss. 6713
Closed Access | Times Cited: 1
Comprehensive profiling of extrachromosomal circular DNAs in colorectal cancer progression
Lu Lu, Mingjie Chen, Guicheng Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top